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Ubiquitylation of proteins can be a signal for a variety of cellular
processes beyond the classical role in proteolysis. The different sig-
naling functions of ubiquitylation are thought to rely on ubiquitin-
binding domains (UBDs). Several distinct UBD families are known,
but their functions are not understood in detail, and mechanisms
for interpretation and transmission of the ubiquitin signals remain
to be discovered. One interesting example of the complexity of
ubiquitin signaling is the Saccharomyces cerevisiae transcription
factor Met4, which is regulated by a single lysine-48 linked polyu-
biquitin chain that can directly repress activity of Met4 or induce
degradation by the proteasome. Here we show that ubiquitin sig-
naling in Met4 is controlled by its tandem UBD regions, consisting
of a previously recognized ubiquitin-interacting motif and a novel
ubiquitin-binding region, which lacks homology to known UBDs.
The tandem arrangement of UBDs is required to protect ubiquity-
lated Met4 from degradation and enables direct inactivation of
Met4 by ubiquitylation. Interestingly, protection from proteasomes
is a portable feature of UBDs because a fusion of the tandem UBDs
to the classic proteasome substrate Sic1 stabilized Sic1 in vivo in its
ubiquitylated form. Using the well-defined Sic1 in vitro ubiquityla-
tion systemwe demonstrate that the tandemUBDs inhibit efficient
polyubiquitin chain elongation but have no effect on initiation of
ubiquitylation. Importantly, we show that the nonproteolytic reg-
ulation enabled by the tandem UBDs is critical for ensuring rapid
transcriptional responses to nutritional stress, thus demonstrating
an important physiological function for tandem ubiquitin-binding
domains that protect ubiquitylated proteins from degradation.
protein degradation ∣ polyubiquitin chain protection
The ubiquitin/proteasome system governs many aspects ofcellular function such as cell cycle regulation, transcription,
protein localization, and vesicular trafficking. Ubiquitin is a 76-
residue protein that can be covalently attached to substrates by
the E1-E2-E3 cascade of enzymes. Sequential addition of ubiqui-
tin forms polyubiquitin chains, which are best known for their role
as a degradation signal, but important proteolysis-independent
functions of these chains are emerging as well (1, 2). Distinct sig-
naling functions of ubiquitylation can be determined by the type
of ubiquitylation, such as monoubiquitylation, multiubiquityla-
tion (monoubiquitin attached to several substrate lysines), and
polyubiquitylation with at least 8 different chain topologies found
in vivo. Importantly, the effect of these signals seems to rely on
ubiquitin-binding domains (UBDs) in target proteins (3). UBDs
are often found as a part of ubiquitin receptors and proteins that
promote ubiquitylation or deubiquitylation of substrates. The
first UBD discovered was an ubiquitin-interacting motif (UIM)
in the 26S proteasome subunit S5a/Rpn10 (4). To date, more than
20 distinct UBD families are known, with ubiquitin-associated
domains (UBAs) and UIMs being the most common. The various
functions of UBDs are not understood in detail, but they are
clearly involved in proteasome targeting, substrate ubiquitylation,
and regulation of protein/protein interactions (5). Both the UBA
and UIM domains have also been shown to be able to protect
polyubiquitylated proteins from degradation (6–8), and recently
ubiquitin-binding domains have been used as tools to purify
ubiquitylated proteins (9–11). However, little is known regarding
the mechanism by which UBDs are able to protect ubiquitylated
proteins from degradation and spatial requirements for these
effects remain unexplored. Using the S. cerevisiaeMet4 transcrip-
tion factor we define a portable region containing the previously
identified UIM domain and a previously undescribed UBD that
prevents degradation of ubiquitylated proteins. We show that this
tandem arrangement of ubiquitin-binding domains is necessary
for efficient stabilization of polyubiquitylated proteins in vivo,
and provide in vitro evidence that ubiquitin chain elongation is
affected by the presence of the tandem UBD.
Results
Met4 Contains a Portable Stabilization Domain.Previous studies have
shown that the S. cerevisiae transcription factor Met4 contains a
UIM, which is required for maintaining Met4 in a stable ubiqui-
tylated form (6). This is remarkable becauseMet4 ismodified with
the canonical degradation signal, a K48-linked polyubiquitin
chain, yet Met4 is shielded from proteasomal degradation (12).
Furthermore, the function of this ubiquitin-binding region must
be subject to regulation because protection is lost under some
growth conditions resulting in degradation ofMet4 (13, 14). Thus,
Met4 presents the paradigm for regulatory functions of K-48-
linked polyubiquitin chains and serves as a model system to gain
detailed understanding about control of protein degradation and
nonproteolytic functions for ubiquitylation. To further investigate
this protective function, we tested whether the UIM is contained
in a portable domain. We chose to fuse the 160 N-terminal resi-
dues comprising the UIM to the N-terminus of the well-studied
proteasome substrate Sic1. Several ubiquitylation sites have been
identified in Sic1, so to simplify interpretation of results we used
the single ubiquitin acceptor variant SiclK36, where all lysine
residues except K36 had been mutated (15). SiclK36 functions
similarly to wild-type Sic1 in that it is rapidly polyubiquitylated
and degraded as cells enter S-phase (15). To test whether the
N-terminal region of Met4 can protect Sic1 from degradation
we synchronized cells expressing SiclK36 or Met4ð1-160ÞSiclK36 in
G1, and monitored Sic1 protein levels as cells were released from
the G1 cell cycle block (Fig. 1A). SiclK36 was rapidly degraded as
cells entered S-phase, but Met4ð1-160ÞSiclK36 remained stable and
high molecular weight derivatives of SiclK36 appeared, suggesting
that the N-terminal region of Met4 contains a portable stabiliza-
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tion motif. Protection from degradation was not complete, and
some degradation occurred despite fusion with theMet4 N-termi-
nus. In addition to the significant stabilization, expression of
Met4ð1-160ÞSiclK36, but not SiclK36, blocked cell proliferation
(Fig. 1B). This is consistent with a stabilizing activity in the N-ter-
minus of Met4, because Sic1 degradation is required for G1/S
transition, and cells unable to degrade Sic1 undergo cell cycle
arrest (16).
We next confirmed that the slower migrating species of
Met4ð1-160ÞSiclK36 observed in Fig. 1A were ubiquitylated forms,
because expression of myc-tagged ubiquitin further reduced
mobility, and these low-mobility species of Met4ð1-160ÞSiclK36 were
selectively immunopurified with α-myc antibodies (Fig. 1C).
Furthermore, Met4ð1-160ÞSiclK36 ubiquitylation was dependent on
Sic1’s physiological ubiquitin ligase SCFCdc4 (17, 18) because
high molecular forms were absent in cdc4 mutants (Fig. 1D). In
contrast, Met4 ubiquitylation is catalyzed by SCFMet30 (19, 20)
demonstrating that the protective activity contained in the Met4
N-terminus is an autonomous function, independent from a
specific ubiquitin ligase.
The Distance Between Ubiquitin Acceptor and Stabilization Domain.
We had previously identified lysine-163 as the sole ubiquitin ac-
ceptor site in Met4 (12), which is in close proximity to the UIM
domain located around residue 145 (6). The spacing between ubi-
quitin acceptor site (lysine 36) and UIM in the Met4ð1-160ÞSiclK36
fusion was 30 residues larger than in the native Met4, suggesting
that a precise distance is not essential. To further test the effect
of spacing on the protective function of the Met4-UIM region,
we took advantage of cell growth inhibition by the stabilized
Met4ð1-160ÞSiclK36 fusion and analyzed constructs with three or
six copies of theHA-epitope separating the ubiquitin acceptor site
and the UIM (Fig. 1E). Insertion of HA-epitopes did not signifi-
cantly alter the potent antiproliferative effect of Met4ð1-160ÞSiclK36
constructs, indicating that stabilization was not dependent on a
precise positioning of theMet4-UIM region relative to the ubiqui-
tylation site. This result was further confirmed by measuring the
effect of the HA-epitope insertions on Met4ð1-160ÞSiclK36 stability
using Gal-shut-off experiments. Increasing the distance between
theMet4-UIM and the ubiquitin acceptor site did not significantly
alter the stability of Met4ð1-160ÞSiclK36 (Fig. S1). We are aware that
insertion of spacer regions does not necessarily change proximity
of the two regions in three dimensions. Covalent linkage of the
Met4-UIM region to Sic1 was required for protection, because
expression of the Met4-UIM region in trans could not protect
SiclK36 (Fig. S2). Together these results suggest that stabilization
is achieved in a range of different spatial configurations.
The Met4 Stabilization Domain Inhibits Efficient Polyubiquitin Chain
Elongation in Vitro. Met4 is modified by a relatively short polyubi-
quitin chain. We had previously suggested that the UIM region
located in the Met4 N-terminus restricts polyubiquitin chain
length in vivo (6). To more directly test this idea we made use
of the well-defined Sic1 in vitro ubiquitylation reaction. SiclK36
and Met4ð1-160ÞSiclK36 were produced and purified fromEscherichia
coli, phosphorylated in vitro, and incubated with an SCFCdc4
reaction mix. Both SiclK36 and Met4ð1-160ÞSiclK36 were efficiently
ubiquitylated in vitro, but the presence of the N-terminal region
of Met4 significantly reduced the polyubiquitin chain length
attached to SiclK36 (Fig. 2A and B). A short reaction time course
that captured the linear phase of ubiquitylation showed very
similar rates of modification. Because the overall rate of Sic1
ubiquitylation is directly related to conjugation of the first ubiqui-
tin—the rate limiting step of the reaction—(21), we conclude
that conjugation of the first ubiquitin is not significantly affected
by the Met4 N-terminus (Fig. 2B and C). We did notice slightly
slower ubiquitylation for Met4ð1-160ÞSiclK36 at the very early time
points (Fig. 2C), indicating that the Met4 N-terminus might
have a small effect on conjugation of the first ubiquitin molecule.
However, overall the shorter polyubiquitin chain length on
Fig. 1. (A). Met4ð1-160ÞSiclK36 is stable and leads to cell cycle arrest. (A) Cells expressing RGS6His tagged SiclK36 or Met4ð1-160ÞSiclK36 under control of the GAL1
promoter were synchronized in G1 using α-factor. Cells were released from the G1 arrest and expression from the GAL1 promoter was blocked by shifting cells
to dextrose media. Protein levels were monitored at indicated time points. (B) Cells as in (A) were plated on dextrose (no expression) or galactose (expression)
media. (C) Cells expressing RGS6His-SiclK36 or RGS6His-Met4ð1-160ÞSiclK36 were transformed with either untagged ubiquitin or myc-ubiquitin. Ubiquitylated pro-
teins were immunopurified using α-myc antibodies and samples were analyzed by immunoblotting using RGS6His antibodies. The signal detected for unmo-
dified RGS6His-Met4ð1-160ÞSiclK36 in the “myc-IP” lanes is due to low nonspecific binding to the α-myc resin. (D) WT or cdc4-3 cells expressing RGS6His-SiclK36 or
RGS6His-Met4ð1-160ÞSiclK36 were shifted to the restrictive temperature (37 °C) and whole cell lysates were analyzed by immunoblotting with RGS6His antibodies.
(E) Cells expressing the indicated proteins under control of the inducible GAL1 promoter were plated in serial dilutions on either dextrose media or galactose
media. “H” refers to 3 copies of the HA epitope.
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Met4ð1-160ÞSiclK36 is likely predominantly due to inhibition of chain
elongation, probably by stochastic capping of the terminal ubiqui-
tin moiety. Similar inhibition of polyubiquitin chain extension has
been observed after addition of Rad23 to in vitro reactions, which
contains two UBA domains and can interact with polyubiquitin
chains (9, 22).
Two Conserved Domains are Important for Polyubiquitin Chain Protec-
tion. We next created a series of truncations of the Met4 N-ter-
minus to identify the minimal region required for protection from
degradation. Truncations beyond residue 82 were significantly
less potent in stabilizing Sic1, as indicated by increased cell pro-
liferation (Fig. 3A), and reduction in steady-state levels of ubiqui-
tylated forms of Sic1 (Fig. 3B). This was unexpected because all
analyzed truncations contained the UIM domain (residues 135–
155). We suspected that an additional domain located between
residue 83 and the previously characterized UIM was required
for stabilization of polyubiquitylated proteins. Indeed, alignment
of Met4 from different yeast species identified a highly conserved
region between residues 86 and 96 (Fig. S3). To test the impor-
tance of this region in protecting ubiquitylated Sic1, we expressed
Met4ð1-160ÞSiclK36 fusion proteins containing either deletions of
region 86–96 (referred to as D1), deletion of the previously
defined UIM (144–149) (referred to as D2 in Fig. 3C), or both
domains and analyzed cell proliferation (Fig. 3C). Deletion of
either D1 or D2 allowed partial cell proliferation, and mutations
in both regions almost completely abolished the stabilizing activ-
ity of the Met4 N-terminal region, indicating that both D1 and
D2 are important for stabilizing ubiquitylated SiclK36.
Met4 Residues 86–96 Define a Ubiquitin-Binding Domain. We next
assessed the importance of the Met4 region 86–96 (D1) for bind-
ing to ubiquitin in vitro. GST-tagged versions of the N-terminal
160 residues of Met4 with small deletions of domains D2 (UIM),
D1 (∆86–96), or both D1 and D2 were expressed in E. coli, im-
mobilized on glutathione beads, and incubated with K-48 linked
polyubiquitin chains ranging from monoubiquitin to seven ubi-
quitins. Bound fractions were analyzed by immunoblotting with
α-ubiquitin (Fig. 3D). Met4(1–160) did not bind monoubiquitin
but efficiently bound polyubiquitin chains ranging from 3 to 7
ubiquitin residues. Deletion of D1 or D2 (UIM) significantly
reduced binding, and combined mutations in the two regions
completely abolished binding to polyubiquitin chains. Previous
experiments with the N-terminal 270 residues of Met4 and radi-
olabeled K48-tetra ubiquitin showed a more dramatic effect of
the UIM mutation (6). It is unclear whether this is due to the use
of a larger Met4 fragment or because of differences in the poly-
ubiquitin chains used. The previous study relied on polyubiquitin
chains formed with ubiquitin in which all lysine residues except
K48 had been mutated to alanine, whereas this study used com-
mercial chains, which have a K29R mutation but are otherwise
unmodified. Interestingly, none of the N-terminal Met4 frag-
ments bound mono- or diubiquitin.
These results suggested that both the UIM and D1 define do-
mains that bind polyubiquitin chains. However, it was formally
possible that both regions are part of one larger domain, although
this was unlikely because the Met4-UIM region is clearly a
member of the well-defined UIM family (6, 23). Nevertheless,
to address this question in vivo, we generated Met4ð1-160ÞSiclK36
fusions with tandem copies of either the UIM (residues 131–160
duplicated) or D1 (residues 86–112 duplicated). Both tandem
configurations were significantly more potent in stabilizing Sic1
as compared to the single domain mutations (Fig. 3E). Most
importantly, the construct containing duplication of region D1
lacked the UIM but was nevertheless potent in protecting Sic1
from degradation. Together the in vitro binding assay (Fig. 3D)
and in vivo protection results (Fig. 3E) strongly support that
domains D1 and D2 are independent ubiquitin-binding domains
that act in concert to protect polyubiquitylated proteins from
degradation. Whereas the UIM is well-defined, the region be-
tween residues 86–96 lacks key residues characteristic of the cano-
nical UIM (23). However, this unique ubiquitin-binding motif
clearly shares several features with UIMs such as the small size
and a predicted alpha-helical structure. We termed this motif
a UIM-like domain.
Met4 Is Regulated by Two Ubiquitin-Binding Domains.During normal
growth conditions Met4 is usually sequestered in an inactive,
polyubiquitylated form, which is protected from the proteasome
(12–14, 19). To evaluate the contribution of the individual ubiqui-
Fig. 2. Fusion ofMet41-160 to the N-terminus of the single lysine substrate SiclK36 is inhibitory for polyubiquitin chain elongation but not for transfer of the first
ubiquitin to substrate. (A) Time-course comparing the ubiquitylation of SiclK36 (lanes 1–6) or Met4ð1-160ÞSiclK36 (lanes 7–12). Notice that ubiquitylated SiclK36
migrates higher in the gel than ubiquitylated Met4ð1-160ÞSiclK36, which is indicative of a higher degree of modification. (B) same as (A), except the time-course
has been shortened to capture the initial linear phase of the ubiquitylation reaction. (C) Graph showing the rate of Sic1 ubiquitylation, where substrate is
defined as unmodified SiclK36 or Met4ð1-160ÞSiclK36 and product is substrate modified by one or more ubiquitins. Each graphical data point represents the mean of
triplicate data values from three independent experiments, and the error bars are the standard deviations for those measurements.
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tin-binding domains to Met4 stabilization, we expressed various
Met4 D1 and D2 mutants under control of the MET4 promoter
and analyzed steady-state levels (Fig. 4A). Mutations in either
region or their combination led to a significant decrease in Met4
steady-state levels. Reduced Met4 levels were due to SCFMet30-
dependent degradation because deletion of MET30 not only
abolished Met4 ubiquitylation but also restored normal steady-
state levels of Met4 (Fig. 4A). We noted that mutations in the
UIM region also changed the phosphorylation pattern, but the
significance of this observation is still unknown (Fig. 4A). To
further characterize the importance of the UIM-like domain,
we measured degradation of Met4 mutants (Fig. 4B). Wild-type
Met4 was very stable and mutations in the UIM or the UIM-like
region significantly destabilized Met4. Importantly, Met4 lacking
both UIM and UIM-like functions was degraded faster than
either single domain mutant (Fig. 4B). Thus, the presence of
the UIM and UIM-like domains convert a highly unstable protein
with a half-life of less than 5 min to an almost completely stable,
yet K48-polyubiquitylated protein.
To address the biological importance of the UIM and UIM-like
domains we tested the transcriptional response of Met4 D1 and
D2 mutants to methionine stress. As previously suggested, main-
taining a pool of inactive, polyubiquitylated Met4 rather than
inactivation by degradation should allow cells to react more
rapidly to environmental and nutrient stress (6). To test this hy-
pothesis we compared wild-type Met4 and mutants lacking
individual or both UBDs. We first confirmed that in contrast to
wild-type Met4, whose transcriptional activity is controlled by
polyubiquitylation independently of proteolysis, polyubiquityla-
tion regulates the mutant versions of Met4 at the level of protein
abundance (Fig. 4C). To this end, cells expressing endogenous
levels of Met4 were shifted to methionine-lacking medium to
activateMet4. As expected, the levels of wild-typeMet4 remained
constant but a dramatic change inmodification from the transcrip-
tionally inactive polyubiquitylated species to phosphorylated
active forms was evident. In contrast,Met4mutants lackingUBDs
responded to methionine depletion by accumulation of Met4
protein levels. We next followed induction kinetics for the Met4-
dependent gene MET25 in response to methionine depletion
(Fig. 4D). Cells expressing wild-typeMet4 responded significantly
faster to nutritional stress than either single UBD or double UBD
mutants. These results support the notion that the UBD regions
in Met4 allow proteolysis-independent regulation by polyubiqui-
tylation, which permits a more rapid response to nutrient stress
than regulation by ubiquitin-mediated degradation.
Discussion
Our study defines a tandem ubiquitin-binding domain in the
N-terminus of the transcription factor Met4 that protects polyu-
biquitylated proteins fromdegradation by the proteasome. Impor-
tantly, the tandem UBDs of Met4 function autonomously in
that they can be functionally fused to other proteins. Ubiqui-
tin-associated domains (UBAs), which also bind ubiquitin, have
previously been reported to protect proteins in cis from degrada-
tion by the proteasome (7, 24). However, the mechanism of
stabilization seems to be different from that of the N-terminal
region in Met4. A recent report suggests that protein stabilization
by UBA domains does not correlate with the ability to bind ubi-
quitin, but rather with the structural integrity of the domain (24).
UBA domains might thus interfere with processes at the protea-
some and not with recognition of ubiquitylated substrates by
the proteasome. Consistent with this idea, fusion of the UBA2
Fig. 3. Met41-160 contains two ubiquitin-binding domains. (A) Cells expressing SiclK36 or Met4SiclK36 fusions under control of the inducible GAL1 promoter were
plated in serial dilutions on either dextrose or galactose media. (B) Whole cell lysates from cells expressing RGS6His tagged SiclK36 or versions of Met4SiclK36
fusions were analyzed by immunoblotting with RGS6His antibodies. (C) Cells expressing the indicated proteins under control of the inducible GAL1 promoter
were plated in serial dilutions on either dextrose media or galactose media. Region D1 represents residues 86–96, D2 represents previously defined UIM
residues 144–149. (D) GST-tagged Met41-160 and deletion mutants were expressed in E. coli, purified on glutathione beads, and incubated with K48-linked
polyubiquitin chains. (Left) Purified fractions were separated by SDS-PAGE and probed with α-ubiquitin antibodies. Quantitation of signal intensities are shown
at the bottom. (Right) Amido black staining of purified GST-tagged proteins. (E) Cells expressing the indicated proteins under control of the inducible GAL1
promoter were plated in serial dilutions on either dextrose media or galactose media.
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domain of Rad23 to SiclK36 completely stabilized Sic1, but the vast
majority of UBA2SiclK36 was in its deubiquitylated form (Fig. S4).
This is in stark contrast to the function of theMet4 tandemUBDs,
which stabilized Sic1 mainly as ubiquitylated species. The me-
chanism of stabilization by the Met4 tandem UBDs is therefore
distinct from UBA-mediated stabilization.
To the best of our knowledge, we report here a unique example
of a physiologically relevant domain that protects proteins in their
ubiquitylated form from degradation by the proteasome. By pro-
tecting the ubiquitylated form of a protein, the tandem UBDs of
Met4 enable the polyubiquitin chain to function as an activity
switch that is independent of proteolysis.We demonstrate that this
ubiquitylation-based regulatory mechanism uncouples the cellu-
lar response to nutrient stress from new protein synthesis and
therefore makes possible a faster adaptation to stress. How and
why a canonical degradation signal (K48-polyubiquitin chain)
evolved to be a functionally different regulatory device is not
completely clear, in part because cells could simply use monou-
biquitylation or regulatory K63-polyubiquitin chains instead.
However, under certain physiological growth conditions Met4
is degraded by the proteasome (13, 14, 25), and a conditional
degradation signal that is masked by the tandem UBDs under
normal growth conditions might be an effective way to integrate
several regulatory pathways. Interestingly, such a conditional
degradation function implies that the protective function of the
Met4 tandem UBDs is regulated either by posttranslational mod-
ifications or specific binding proteins that neutralizeUBDactivity.
Tandem ubiquitin-binding domains are frequently observed in
proteins (23), and it has recently been shown that polyubiquitin-
chain topology-specific binding can be achieved by such tandem
UBDs (26). Our results demonstrate that the tandem arrange-
ment of ubiquitin-binding domains can have important physiolo-
gical functions by protecting ubiquitylated forms of proteins from
degradation by the 26S proteasome. Tandem ubiquitin-binding
domains might thus be critical mediators of the functions of
ubiquitylation that do not involve proteolysis.
Materials and Methods
Protein Analysis. Lysis conditions for immunoblotting (denaturing conditions
in urea-buffer) and immunopurification (Triton-buffer) were as described (6).
Antibodies used in this study were as follows: α-myc 9E10 (1∶2000; Covance),
α-RGS4H (1∶2000; Qiagen), and α-ubiquitin P4G7 (1∶2000; Santa Cruz Biotech-
nology) for immunoblotting. α-myc antibodies (SC-789-G; Santa Cruz Biotech-
nology, CA) for immunopurification.
Ubiquitin Binding. E. coli expressing GST or GST-tagged Met4 variants were
lysed in Triton-buffer (6). Proteins were bound to glutathione beads (50 μL
bead slurry/1 mg protein) for 4 h at 4 °C, beads were washed, and incubated
with 5 μg K48-linked polyubiquitin chains Ub2-7 (Enzo Life Sciences Interna-
tional, Inc.) in 50 μL Ub binding buffer (0.05% NP-40, 20 mM Tris, pH 7.5,
10 mM NaCl, 25 μg∕mL BSA) for 1 h at room temperature. Ubiquitin binding
was analyzed by immunoblotting.
Yeast Methods and Protein Half-Life. Standard yeast methods and growth con-
ditions were used (27). For the spot assays, cells were grown to A600 ¼ 0.5 and
serially diluted in 5-fold increments starting with 5000 cells. Cells were
spotted onto the indicated agar plates. To measure Sic1 degradation cells
expressing Sic1 fusions as indicated under control of theGAL1 promoter were
grown in galactose containing medium to an A600 ¼ 0.3 and synchronized in
G1 with 0.1 μg∕mL α-factor for 3 h. Cells were released from the pheromone
arrest in dextrose containing media to block production of Sic1 fusion
constructs and samples were analyzed at the time intervals as indicated by
immunoblotting. To measure Met4 protein stability, cells expressing Met4
under control of the native promoter were cultured in richmedium (1% yeast
extract, 2% peptone, 2% dextrose) to A600 ¼ 0.6. Cycloheximide was added
to a final concentration of 0.2 mg∕mL to block protein synthesis, and cell
lysates were analyzed by immunoblotting.
Fig. 4. Both Met4 ubiquitin-binding domains are required to maintain stably polyubiquitylated Met4. (A) Steady-state levels of Met4 or Met4 ubiquitin-
binding domainmutants expressed from theMET4 promoter in wild-type cells ormet30Δmutants. (B) Cells expressingMet4 or Met4 ubiquitin-binding domain
mutants under the endogenous promoter were treated with cycloheximide to block protein expression, and samples as indicated were analyzed by immuno-
blotting. (C) Cells expressing the indicated proteins under control of theMET4 promoter were grown to midlog phase in medium containing methionine. Cells
were then shifted to medium lacking methionine to activate Met4 and samples as indicated were analyzed by immunoblotting. (D) Experiment as in (C), but
RNA levels of the Met4 target gene MET25 were analyzed by RT-qPCR and plotted normalized to actin (ACT1).
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In Vitro Ubiquitylation Aassay. G1-CDK and SCF were expressed and purified
from insect cells as previously described (28). Both SiclK36 and Met4ð1-160ÞSiclK36
were phosphorylated and labeled with 32P at a final concentration of ∼12 μM
(28). Ubiquitylation reactions were carried out in 30 mM Tris, pH 7.5, 50 mM
NaCl, 5 mMMgCl2, 2 mMATP, and 2mM dithiothreitol. In a 1.5 mL eppendorf
tube, 200 nM SCF, 0.8 μM E1, 10 μM Cdc34, and 60 μM ubiquitin were briefly
incubated at 22 °C and the reactions were initiated by the addition of 1.2 μM
SiclK36 or Met4ð1-160ÞSiclK36. Time-points were extracted from the reaction
mixture (30 μL) and quenched with reducing SDS-PAGE buffer. The samples
were then separated on a 10% Tris-glycine SDS-PAGE gel, which was dried
and exposed to a phosphor screen for analysis. Quantification was performed
with ImageQuant (GE Healthcare) and plotted using Prism. The rate of ubi-
quitylated Sic1 product formation was calculated by dividing the quantity of
all ubiquitylated Sic1 species (product) by the sum of unmodified substrate
and product and then multiplying by 36 pmol.
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